About 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide
2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide (PubChem CID 19063694) has the molecular formula C33H31N5O3
and a molecular weight of 545.64 g/mol. Its IUPAC name is 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide.
Molecular Properties
| Compound Name | 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide |
| PubChem CID | 19063694 |
| Molecular Formula | C33H31N5O3 |
| Molecular Weight | 545.64 g/mol |
| Exact Mass | 545.24 |
| IUPAC Name | 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide |
| SMILES | CC(C)N(C(=O)CN1C(=O)C(NC(=O)Nc2ccccc2)N=C(c2ccccc2)c2ccccc21)c1ccccc1 |
| InChI | InChI=1S/C33H31N5O3/c1-23(2)38(26-18-10-5-11-19-26)29(39)22-37-28-21-13-12-20-27(28)30(24-14-6-3-7-15-24)35-31(32(37)40)36-33(41)34-25-16-8-4-9-17-25/h3-21,23,31H,22H2,1-2H3,(H2,34,36,41) |
| InChIKey | PBQXFIKAKXNUTA-UHFFFAOYSA-N |
| XLogP | 5.46 |
| TPSA | 94.11 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 545.64 |
| LogP ≤ 5 | 5.46 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Analyze 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide?
The IUPAC name of 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide (CID 19063694) is 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide.
What is the SMILES notation for 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide?
The canonical SMILES for 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide is CC(C)N(C(=O)CN1C(=O)C(NC(=O)Nc2ccccc2)N=C(c2ccccc2)c2ccccc21)c1ccccc1.
What is the InChIKey of 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide?
The InChIKey is PBQXFIKAKXNUTA-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H31N5O3/c1-23(2)38(26-18-10-5-11-19-26)29(39)22-37-28-21-13-12-20-27(28)30(24-14-6-3-7-15-24)35-31(32(37)40)36-33(41)34-25-16-8-4-9-17-25/h3-21,23,31H,22H2,1-2H3,(H2,34,36,41).
What are the key properties of 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide?
2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide has a molecular weight of 545.64 g/mol, XLogP of 5.46, 7 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]-N-phenyl-N-propan-2-ylacetamide is sourced from PubChem (CID 19063694), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).